Señales en vivo de CDXS | Maximiza tus Ganancias con Getagraph.com

VENDER 116699 min ago

@ $2.88

Emitido: 14 feb 2024 @ 09:31

Retorno: 36.15%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: 0.67 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	1.69M
Volumen promedio	574 708
Capitalización de mercado	276.59M
EPS	$0 ( 2024-05-02 )
Próxima fecha de ganancias	( $-0.180 ) 2024-06-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.50
ATR14	$0.00600 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-01	Ryali Sriram	Buy	314 125	Stock Option (Right to Buy)
2024-01-01	Ryali Sriram	Buy	52 350	Common Stock
2024-01-01	Norrett Kevin	Buy	314 125	Stock Option (Right to Buy)
2024-01-01	Norrett Kevin	Buy	52 350	Common Stock
2024-01-01	Fitzgerald Margaret Nell	Buy	314 125	Stock Option (Right to Buy)

INSIDER POWER
79.19
Last 93 transactions
Buy: 6 649 590 \| Sell: 1 047 461

Volumen Correlación

Largo: 0.20 (neutral)

Corto: 0.27 (neutral)

Signal:(61.236) Neutral

Codexis Inc Correlación

10 Correlaciones Más Positivas
ZD	0.978
SRTS	0.967
LGHL	0.958
NWL	0.954
NMTR	0.952
TBNK	0.952
GDS	0.95
MODV	0.949
WMG	0.949
TRIP	0.948

10 Correlaciones Más Negativas
MTRY	-0.947
AHRN	-0.943
AFAR	-0.94
FRSG	-0.939
MCAA	-0.938
TBSA	-0.934
LEGA	-0.933
CITE	-0.932
NBSTU	-0.931
MSDA	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Codexis Inc Correlación - Moneda/Commodity

0.02
( neutral )

0.09
( neutral )

0.00
( neutral )

0.01
( neutral )

0.27
( neutral )

Codexis Inc Finanzas

Annual	2023
Ingresos:	$70.14M
Beneficio Bruto:	$51.82M (73.87 %)
EPS:	$-1.120

FY	2023
Ingresos:	$70.14M
Beneficio Bruto:	$51.82M (73.87 %)
EPS:	$-1.120

FY	2022
Ingresos:	$138.59M
Beneficio Bruto:	$100.56M (72.56 %)
EPS:	$-0.510

FY	2021
Ingresos:	$104.75M
Beneficio Bruto:	$82.55M (78.80 %)
EPS:	$-0.330

Financial Reports:

No articles found.

Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.